Correlation Between Cullinan Oncology and Biomea Fusion
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Biomea Fusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Biomea Fusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Biomea Fusion, you can compare the effects of market volatilities on Cullinan Oncology and Biomea Fusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Biomea Fusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Biomea Fusion.
Diversification Opportunities for Cullinan Oncology and Biomea Fusion
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cullinan and Biomea is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Biomea Fusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomea Fusion and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Biomea Fusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomea Fusion has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Biomea Fusion go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Biomea Fusion
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.69 times more return on investment than Biomea Fusion. However, Cullinan Oncology LLC is 1.44 times less risky than Biomea Fusion. It trades about 0.07 of its potential returns per unit of risk. Biomea Fusion is currently generating about 0.0 per unit of risk. If you would invest 753.00 in Cullinan Oncology LLC on July 18, 2025 and sell it today you would earn a total of 110.00 from holding Cullinan Oncology LLC or generate 14.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Biomea Fusion
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Biomea Fusion |
Cullinan Oncology and Biomea Fusion Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Biomea Fusion
The main advantage of trading using opposite Cullinan Oncology and Biomea Fusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Biomea Fusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomea Fusion will offset losses from the drop in Biomea Fusion's long position.| Cullinan Oncology vs. Monte Rosa Therapeutics | Cullinan Oncology vs. Design Therapeutics | Cullinan Oncology vs. Erasca Inc | Cullinan Oncology vs. Vor Biopharma |
| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world |